A network-based deep learning model integrating subclonal architecture for therapy response prediction in cancer.

0.62), with a marginally significant difference ( Figures 2 B and 2C; labeled “network-based deep learning,” Wilcoxon signed-rank test, p < 0.05).

also in 26,082 other papers